Welcome to the ADIS project

ADIS stands for “Early Diagnosis of Alzheimer’s Disease by Immune Profiling of Cytotoxic Lymphocytes and Recording of Sleep Disturbances”. The research project brings together EU-leading expertise in data science, biotechnology, clinical research as well as public involvement.

As the title already highlights, the partners aim to advance research into one of the most challenging conditions, Alzheimer’s disease.

Our mission is to strive for earlier diagnosis of Alzheimer’s disease.

Latest news

Spotlight on early career researchers An interview with Sarah Hücker
31
May

Spotlight on early career researchers: An interview with Sarah Hücker

In this spotlight on early career researchers interview we talk with Sarah Hücker, PostDoc at...
Read More
25
Apr

The value of being informed of having Alzheimer’s disease in the stage of Mild Cognitive Impairment

On 25 April, members of the ADIS Advisory Board gathered online for a consultation on...
Read More
Spotlight on early career researchers: an interview with Sophia Krix
08
Mar

Spotlight on early career researchers: An interview with Sophia Krix

In this spotlight on early career researchers interview we talk with Sophia Krix, a PhD...
Read More

Subscribe to our newsletter

  • Prof. Dr. Holger Fröhlich
    Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)

    ADIS will leverage cutting edge science and technology in conjunction with long lasting clinical expertise to provide candidate biomarkers for earlier diagnosis of Alzheimer’s disease. An earlier diagnosis means that treatments slowing down symptom worsening would have higher success chance in the future and that patients could better plan their life. I am very enthusiastic about the motivation and energy of the entire consortium to reach our ambitious goals and really looking forward to the upcoming three years of working together.

  • Vanessa Lage-Rupprecht
    Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)

    Coming soon.